Cancer Cachexia Society EIN No. 83-1771930
Welcome
Cachexia is the unintentional weight loss caused by tumors. Cachexia includes symptoms of low appetite (anorexia), weakness, tiredness/fatigue, weight loss, fat and muscle loss. These symptoms result from tumor-induced changes in metabolism and inflammation. Cachexia contributes to poor outcomes in cancer including reduced response to therapy. Currently there are few approved treatments for cancer cachexia, but the outlook for interventions in cancer cachexia is improving with growth of research and clinical testing.
The Cancer Cachexia Society is a community of basic scientists, translational researchers, clinician-investigators, health care providers, industry partners, advocates, and patients. We work together to increase knowledge, research, education, awareness, and treatment of cachexia. Through international conferences, a monthly seminar series, research and educational resources, and social media interactions for patients and professionals, we aim to leverage the expertise of our community to make powerful change for people with cancer.
Please join us in our work to end suffering from cancer cachexia.
Cancer Cachexia Society Seminar Series
Hosted by the Education Committee
November 13, 2024 at 12:00 PM EST / 6:00 PM CET
Cancer Cachexia Clinical Trial Design
Professor Barry J A Laird
Chair of Palliative and Supportive Care Institute of Genetics and Cancer, University of Edinburgh
Professor Richard Skipworth
Clinical Surgery, Royal Infirmary of Edinburgh and University of Edinburgh
The speakers will discuss recent clinical trials, focusing on essential methodological aspects that enhance research quality. They will also provide an overview of ongoing work related to cancer cachexia endpoints, emphasizing their significance in improving patient care and treatment outcomes.
To join us please REGISTER in advance via the following Zoom link:
https://us02web.zoom.us/webinar/register/WN_5V5jefrsSQ6e_Ydd8qwUKQ
